logo-loader

Creo Medical Group "gaining a level of acceptance" in endoscopy

Published: 07:25 23 May 2023 EDT

 

Creo Medical Group PLC (AIM:CREO) CEO Craig Gulliford speaks to Thomas Warner from Proactive about the latest developments at the medical device company, following a successful appearance at Digestive Disease Week.

Gulliford says that Creo Medical is "gaining a level of acceptance" both within its home market the UK and beyond, highlighting increasing interest from the burgeoning Asian market.
 

Alvopetro posts 86% net back margin as Q2 volumes jump 26% and Murucututu...

Alvopetro Energy Ltd (TSX-V:ALV, OTC:ALVOF, FRA:A6Y0) CEO Corey Ruttan tells Proactive's Stephen Gunnion that Q2 2026 sales volumes averaged 3,067 barrels of oil equivalent per day, up 26% year-on-year, with revenue of just over $19 million and funds flow from operations of $14.1...

23 hours, 2 minutes ago